Drug Profile
Research programme: typhoid Vi vaccine - DelSite Biotechnologies
Latest Information Update: 20 Oct 2009
Price :
$50
*
At a glance
- Originator DelSite Biotechnologies
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Typhoid
Most Recent Events
- 16 Jul 2008 qc